Triple-S Management Corp
NYSE:GTS
Relative Value
There is not enough data to reliably calculate the relative value of GTS.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
GTS Competitors Multiples
Triple-S Management Corp Competitors
Market Cap | P/S | P/E | P/B | ||||
---|---|---|---|---|---|---|---|
PR |
Triple-S Management Corp
NYSE:GTS
|
856.4m USD | 0.2 | 10.5 | 0.8 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
462.3B USD | 1.2 | 30.1 | 5 | ||
US |
Elevance Health Inc
NYSE:ELV
|
123.9B USD | 0.7 | 19.8 | 3.1 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | 18.6 | 3.2 | ||
US |
Centene Corp
NYSE:CNC
|
40.7B USD | 0.3 | 14.9 | 1.5 | ||
US |
Humana Inc
NYSE:HUM
|
38.9B USD | 0.4 | 19.5 | 2.4 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20.4B USD | 0.6 | 19 | 4.5 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.7B USD | 6.7 | 119.8 | 3.3 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | 45.5 | 4.6 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
30.5B BRL | 1.1 | -41.3 | 0.6 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
3.1B USD | 2.9 | 50.7 | 5.7 |